Abvc Biopharma ABVC
NASDAQ ABVC
$0.98 +0.01 (+0.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Preferred Dividend Payments (2010 - 2012)

Abvc Biopharma's (ABVC) quarterly Preferred Dividend Payments came in at -$63333.0 in Q2 2012, up 81.0% on a YoY basis from -$34990.6 in Q3 2011, and down 151.02% quarter-over-quarter from -$25230.0 in Q1 2012.

Analysis

Abvc Biopharma (ABVC) Preferred Dividend Payments (2010 - 2012) Analysis & Trends

Abvc Biopharma (ABVC) has reported Preferred Dividend Payments for 3 consecutive years, with -$63333.0 the latest figure, recorded in Q2 2012.

  • For the quarter ending Q2 2012, Preferred Dividend Payments rose 81.0% year-over-year to -$63333.0; the trailing twelve-month figure through Jun 2012 stood at $1.3 million (up 403.72% YoY), and the FY2011 full-year result was -$92497.0, up 50.41% from the prior year.
  • Preferred Dividend Payments retreated to -$63333.0 in Q2 2012 per ABVC's latest filing, from -$25230.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $1.4 million in Q3 2011 and bottomed at -$333334.0 in Q2 2011.
  • Historically, Preferred Dividend Payments has averaged $91623.8 across 3 years, with a median of -$30972.0 in 2010.
  • The widest YoY moves for Preferred Dividend Payments: up 3211.57% in 2011, down 651.62% in 2011.
  • Over 3 years, Preferred Dividend Payments stood at -$30972.0 in 2010, then climbed by 29.7% to -$21772.0 in 2011, then tumbled by 190.89% to -$63333.0 in 2012.
  • According to Business Quant data, Preferred Dividend Payments over the past three periods registered -$63333.0, -$25230.0, and -$21772.0 for Q2 2012, Q1 2012, and Q4 2011 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Abvc Biopharma 25.56 Mn 25.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 -63,333.00
Mar 31, 2012 -25,230.00
Dec 31, 2011 -21,772.00
Sep 30, 2011 1.41 Mn
Jun 30, 2011 -333,334.00
Mar 31, 2011 -17,052.00
Dec 31, 2010 -30,972.00
Sep 30, 2010 -45,181.00
Jun 30, 2010 -44,349.00